TME PHARMA NV (ALTME.PA)
NL0015000YE1 - Common Stock
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.32M | -6.73M | -15.13M | -14.45M | -10.41M | |||
| Depreciation Amortization | 130.00K | 144.00K | 92.00K | 70.00K | 60.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 67.00K | -561.00K | -720.00K | 410.00K | 360.00K | |||
| Interest Paid | 5.00K | 13.00K | 11.00K | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 6.00K | 0.00 | N/A | N/A | |||
| Other non cash items | 1.15M | 1.52M | 3.61M | 1.60M | 4.76M | |||
| OPERATING CASH FLOW | -4.98M | -5.63M | -12.14M | -12.38M | -5.22M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.00K | -19.00K | -21.00K | -10.00K | -40.00K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | -7.00K | -19.00K | -21.00K | -10.00K | -40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.21M | -39.00K | 7.37M | 4.35M | 5.69M | |||
| Stock Issued/Repurchased | 5.77M | 3.17M | 56.00K | 7.22M | 8.79M | |||
| Other Financing Activity | 1.11M | 140.00K | -145.00K | -70.00K | -300.00K | |||
| FINANCING CASH FLOW | 4.68M | 3.27M | 7.29M | 11.50M | 14.18M | |||
| Exchange Rate Effect | -2.00K | -1.00K | 57.00K | 50.00K | N/A | |||
| CHANGE IN CASH | -310.00K | -2.39M | -4.82M | -840.00K | 8.92M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.98M | -5.63M | -12.14M | -12.38M | -5.22M | |||
| Capital Expenditure | -3.00K | -19.00K | -21.00K | -10.00K | -40.00K | |||
| FREE CASH FLOW | -4.98M | -5.65M | -12.16M | -12.39M | -5.26M | |||
All data in EUR